These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11114100)

  • 1. Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy.
    Chakrabarti S; Cukiernik M; Hileeto D; Evans T; Chen S
    Diabetes Metab Res Rev; 2000; 16(6):393-407. PubMed ID: 11114100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Advances in the molecular understanding of growth factor action underlying diabetic retinopathy].
    Ishibashi T
    Nippon Ganka Gakkai Zasshi; 2000 Oct; 104(10):697-8. PubMed ID: 11081303
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathophysiology of Diabetic Retinopathy.
    Funatsu H; Yamashita H
    Drug News Perspect; 2002 Dec; 15(10):633-639. PubMed ID: 12677248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of growth factors in the development of diabetic complications.
    Chiarelli F; Santilli F; Mohn A
    Horm Res; 2000; 53(2):53-67. PubMed ID: 10971090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy.
    Miller JW; Adamis AP; Aiello LP
    Diabetes Metab Rev; 1997 Mar; 13(1):37-50. PubMed ID: 9134347
    [No Abstract]   [Full Text] [Related]  

  • 6. Growth factors and diabetic retinopathy.
    Paques M; Massin P; Gaudric A
    Diabetes Metab; 1997 Apr; 23(2):125-30. PubMed ID: 9137900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of retinal neovascularization in diabetic retinopathy.
    Takagi H
    Intern Med; 2003 Mar; 42(3):299-301. PubMed ID: 12705804
    [No Abstract]   [Full Text] [Related]  

  • 8. Shedding light on blindness.
    Barinapa M
    Science; 1995 Jan; 267(5197):452-3. PubMed ID: 7824943
    [No Abstract]   [Full Text] [Related]  

  • 9. Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels.
    Murata T; Ishibashi T; Khalil A; Hata Y; Yoshikawa H; Inomata H
    Ophthalmic Res; 1995; 27(1):48-52. PubMed ID: 7596559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of vascular endothelial growth factor in microvascular abnormalities in diabetic retinopathy].
    Takagi H
    Nihon Ronen Igakkai Zasshi; 2000 Aug; 37(8):603-6. PubMed ID: 11086383
    [No Abstract]   [Full Text] [Related]  

  • 11. Vascular endothelial growth factor and retinal neovascularisation: a new therapeutic approach for diabetic retinopathy.
    Favard C; Ortega N; Bayard F; Plouet J
    Diabetes Metab; 1996 Jul; 22(4):268-73. PubMed ID: 8767174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cell biology of intraocular vascular diseases].
    Ishibashi T
    Nippon Ganka Gakkai Zasshi; 1999 Dec; 103(12):923-47. PubMed ID: 10643294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of peritoneal permeability--research in growth factors.
    Devuyst O
    Perit Dial Int; 2001; 21 Suppl 3():S19-23. PubMed ID: 11887818
    [No Abstract]   [Full Text] [Related]  

  • 14. Upregulation of retinal vascular endothelial growth factor mRNAs in spontaneously diabetic rats without ophthalmoscopic retinopathy. A possible participation of advanced glycation end products in the development of the early phase of diabetic retinopathy.
    Segawa Y; Shirao Y; Yamagishi S; Higashide T; Kobayashi M; Katsuno K; Iyobe A; Harada H; Sato F; Miyata H; Asai H; Nishimura A; Takahira M; Souno T; Segawa Y; Maeda K; Shima K; Mizuno A; Yamamoto H; Kawasaki K
    Ophthalmic Res; 1998; 30(6):333-9. PubMed ID: 9731114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between accumulation of advanced glycation end products and expression of vascular endothelial growth factor in human diabetic retinas.
    Murata T; Nagai R; Ishibashi T; Inomuta H; Ikeda K; Horiuchi S
    Diabetologia; 1997 Jul; 40(7):764-9. PubMed ID: 9243096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction between the renin-angiotensin system and vascular endothelial growth factor in the pathogenesis of retinal neovascularization in diabetes.
    Wilkinson-Berka JL; Kelly DJ; Gilbert RE
    J Vasc Res; 2001; 38(6):527-35. PubMed ID: 11740151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of vascular endothelial growth factor in diabetic vascular complications.
    Aiello LP; Wong JS
    Kidney Int Suppl; 2000 Sep; 77():S113-9. PubMed ID: 10997700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo.
    Joussen AM; Poulaki V; Qin W; Kirchhof B; Mitsiades N; Wiegand SJ; Rudge J; Yancopoulos GD; Adamis AP
    Am J Pathol; 2002 Feb; 160(2):501-9. PubMed ID: 11839570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasoactive factors and diabetic retinopathy: vascular endothelial growth factor, cycoloxygenase-2 and nitric oxide.
    Wilkinson-Berka JL
    Curr Pharm Des; 2004; 10(27):3331-48. PubMed ID: 15544519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of diabetic retinopathy with angiopoietin-1.
    Joussen AM; Poulaki V; Tsujikawa A; Qin W; Qaum T; Xu Q; Moromizato Y; Bursell SE; Wiegand SJ; Rudge J; Ioffe E; Yancopoulos GD; Adamis AP
    Am J Pathol; 2002 May; 160(5):1683-93. PubMed ID: 12000720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.